(VIANEWS) - Lazydays Holdings (LAZY), CubeSmart (CUBE), Littelfuse (LFUS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Lazydays Holdings (LAZY)
32.6% sales growth and 35.09% return on equity
Lazydays Holdings, Inc. operates recreation vehicle (RV) dealerships under the Lazydays name in the United States.
Lazydays Holdings's sales growth this year is expected to be 46.9% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 47.7%, now sitting on 1.11B for the twelve trailing months.
Volume
Today's last reported volume for Lazydays Holdings is 131284 which is 12.09% below its average volume of 149342.
Lazydays Holdings's sales growth for the next quarter is 32.6%. The company's growth estimates for the current quarter and the next is 33.9% and 157.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.09%.
Volatility
Lazydays Holdings's last day, last week, and last month's current intraday variation average was 0.65%, 0.97%, and 1.81%, respectively.
Lazydays Holdings's highest amplitude of average volatility was 2.08% (day), 2.66% (last week), and 3.77% (last month), respectively.
Lazydays Holdings's Stock Yearly Top and Bottom Value
Lazydays Holdings's stock is valued at $18.36 at 15:22 EST, way under its 52-week high of $25.74 and way higher than its 52-week low of $15.94.
Lazydays Holdings's Moving Average
Lazydays Holdings's value is under its 50-day moving average of $20.21 and way under its 200-day moving average of $21.88.2. CubeSmart (CUBE)
32.2% sales growth and 11.09% return on equity
CubeSmart is a self-administered and self-managed real estate investment trust.
CubeSmart's sales growth this year is anticipated to be 21.2% and 20.4% for next year.
Year-on-year quarterly revenue growth grew by 23.7%, now sitting on 780.99M for the twelve trailing months.
Volume
Today's last reported volume for CubeSmart is 1062580 which is 32.48% below its average volume of 1573880.
CubeSmart's sales growth for the next quarter is 32.2%. The company's growth estimates for the present quarter and the next is 9.1% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.09%.
Volatility
CubeSmart's last day, last week, and last month's current intraday variation average was 0.42%, 0.66%, and 1.00%, respectively.
CubeSmart's highest amplitude of average volatility was 1.18% (day), 1.78% (last week), and 2.28% (last month), respectively.
CubeSmart's Stock Yearly Top and Bottom Value
CubeSmart's stock is valued at $57.20 at 15:22 EST, below its 52-week high of $57.29 and way higher than its 52-week low of $31.44.
CubeSmart's Moving Average
CubeSmart's worth is above its 50-day moving average of $54.63 and way higher than its 200-day moving average of $48.54.3. Littelfuse (LFUS)
18.6% sales growth and 17.36% return on equity
Littelfuse, Inc. manufactures and sells circuit protection, power control, and sensing products in the Asia-Pacific, the Americas, and Europe.
Littelfuse's sales growth this year is expected to be 40.4% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 37.8%, now sitting on 1.93B for the twelve trailing months.
Volume
Today's last reported volume for Littelfuse is 55368 which is 34.54% below its average volume of 84585.
Littelfuse's sales growth for the next quarter is 18.6%. The company's growth estimates for the current quarter and the next is 30.9% and 19.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.36%.
Volatility
Littelfuse's last day, last week, and last month's current intraday variation average was 3.70%, 1.86%, and 1.38%, respectively.
Littelfuse's highest amplitude of average volatility was 4.50% (day), 2.80% (last week), and 2.52% (last month), respectively.
Littelfuse's Stock Yearly Top and Bottom Value
Littelfuse's stock is valued at $303.48 at 15:22 EST, under its 52-week high of $334.84 and way above its 52-week low of $234.59.
Littelfuse's Moving Average
Littelfuse's value is below its 50-day moving average of $311.32 and above its 200-day moving average of $277.31.4. Stryker Corp (SYK)
12.8% sales growth and 15.68% return on equity
Stryker Corporation operates as a medical technology company.
Stryker Corp's sales growth this year is anticipated to be 20.6% and 7.3% for next year.
Year-on-year quarterly revenue growth grew by 55.4%, now sitting on 16.25B for the twelve trailing months.
Volume
Today's last reported volume for Stryker Corp is 1287050 which is 0.25% above its average volume of 1283760.
Stryker Corp's sales growth for the next quarter is 12.8%. The company's growth estimates for the current quarter and the next is 8.4% and 1.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.68%.
Volatility
Stryker Corp's last day, last week, and last month's current intraday variation average was 0.44%, 0.21%, and 0.83%, respectively.
Stryker Corp's highest amplitude of average volatility was 1.00% (day), 1.47% (last week), and 2.11% (last month), respectively.
Stryker Corp's Stock Yearly Top and Bottom Value
Stryker Corp's stock is valued at $266.71 at 15:22 EST, under its 52-week high of $281.16 and way above its 52-week low of $220.90.
Stryker Corp's Moving Average
Stryker Corp's value is below its 50-day moving average of $268.79 and above its 200-day moving average of $263.78.5. Ituran Location and Control Ltd. (ITRN)
10.4% sales growth and 26.8% return on equity
Ituran Location and Control Ltd., together with its subsidiaries, provides location-based services and wireless communications products.
Ituran Location and Control Ltd.'s sales growth this year is anticipated to be 9.8% and 13.4% for next year.
Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 264.14M for the twelve trailing months.
Volume
Today's last reported volume for Ituran Location and Control Ltd. is 24143 which is 39.86% below its average volume of 40151.
Ituran Location and Control Ltd.'s sales growth for the next quarter is 10.4%. The company's growth estimates for the present quarter and the next is 39.4% and 22.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.8%.
Volatility
Ituran Location and Control Ltd.'s last day, last week, and last month's current intraday variation average was 1.43%, 1.14%, and 1.79%, respectively.
Ituran Location and Control Ltd.'s highest amplitude of average volatility was 3.11% (day), 2.72% (last week), and 3.53% (last month), respectively.
Ituran Location and Control Ltd.'s Stock Yearly Top and Bottom Value
Ituran Location and Control Ltd.'s stock is valued at $25.96 at 15:22 EST, way under its 52-week high of $29.85 and way higher than its 52-week low of $18.26.
Ituran Location and Control Ltd.'s Moving Average
Ituran Location and Control Ltd.'s value is below its 50-day moving average of $26.21 and above its 200-day moving average of $25.13.6. Johnson & Johnson (JNJ)
10.4% sales growth and 26.81% return on equity
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide.
Johnson & Johnson's sales growth this year is anticipated to be 14.1% and 4% for next year.
Year-on-year quarterly revenue growth grew by 27.1%, now sitting on 89.19B for the twelve trailing months.
Volume
Today's last reported volume for Johnson & Johnson is 7698430 which is 2.89% above its average volume of 7481650.
Johnson & Johnson's sales growth is a negative 0% for the ongoing quarter and 10.4% for the next. The company's growth estimates for the ongoing quarter and the next is 7.3% and 19.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.81%.
Volatility
Johnson & Johnson's last day, last week, and last month's current intraday variation average was 0.55%, 0.70%, and 0.61%, respectively.
Johnson & Johnson's highest amplitude of average volatility was 0.88% (day), 1.05% (last week), and 1.09% (last month), respectively.
Johnson & Johnson's Stock Yearly Top and Bottom Value
Johnson & Johnson's stock is valued at $167.84 at 15:22 EST, under its 52-week high of $179.92 and way above its 52-week low of $142.86.
Johnson & Johnson's Moving Average
Johnson & Johnson's worth is higher than its 50-day moving average of $162.51 and higher than its 200-day moving average of $167.48.Previous days news about Johnson & Johnson(JNJ)
- According to Bloomberg Quint on Wednesday, 12 January, "Amgen Inc. could potentially pay billions to Arrakis Therapeutics Inc. through a new RNA collaboration, while Eli Lilly & Co. and Johnson & Johnson have said they're monitoring the emerging field for assets."
- According to Benzinga on Friday, 14 January, "List of companies profiled of the global nephrology drugs market analyzed in the research include AstraZeneca, Akebia Therapeutics, Inc., AbbVie Inc., F. Hoffmann-La Roche, Amgen Inc., GlaxoSmithkline PLC., FibroGen Inc., Pfizer Inc., Johnson & Johnson Inc., and Teva Pharmaceutical Industries Limited."
- According to Bloomberg Quint on Wednesday, 12 January, "A South African Covid-19 vaccine trial will assess the safety and impact of varying doses of Johnson & Johnson and Pfizer Inc. shots as boosters for those infected with HIV as well as the wider population."
- According to VentureBeat on Friday, 14 January, "For its series E round, Verana Health has attracted a slew of big-name strategic and institutional investors, including lead backers Johnson & Johnson Innovation and Novo Growth, as well as GV, Casdin Capital, Brook Byers, the Merck Global Health Innovation Fund, THVC, and Breyer Capital."
7. Acadia Healthcare Company (ACHC)
8% sales growth and 7.61% return on equity
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.
Acadia Healthcare Company's sales growth this year is expected to be 10.4% and 7.4% for next year.
Year-on-year quarterly revenue growth grew by 7.2%, now sitting on 2.26B for the twelve trailing months.
Volume
Today's last reported volume for Acadia Healthcare Company is 169677 which is 59.08% below its average volume of 414674.
Acadia Healthcare Company's sales growth for the next quarter is 8%. The company's growth estimates for the ongoing quarter and the next is a negative 39.8% and 36.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.61%.
Volatility
Acadia Healthcare Company's last day, last week, and last month's current intraday variation average was 0.70%, 0.83%, and 1.59%, respectively.
Acadia Healthcare Company's highest amplitude of average volatility was 4.12% (day), 2.60% (last week), and 3.44% (last month), respectively.
Acadia Healthcare Company's Stock Yearly Top and Bottom Value
Acadia Healthcare Company's stock is valued at $60.76 at 15:22 EST, way below its 52-week high of $68.65 and way above its 52-week low of $48.62.